While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

The potential for sending payloads and people to Mars is therefore becoming plausible in a way that it never has before. Mars ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Nuclear fusion. People on Mars. Artificial general intelligence. These are just some of the advances that could come by the ...